|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 2 | Vascular endothelial growth factor fails to predict response to neoadjuvant chemotherapy for primary breast cancer 显示文摘 | Burcombe RJ Makris A Davies C | 2002 | Breast Cancer Res Treat2002，761，： | 1 |
| 3 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracy-cline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | British Journal of Can-cer2005，92，1： | 1 |
| 4 | Evaluation of ER,PgR,HER2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makrie A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 5 | Vascular endothelial growth factor fails to predoct response to neoadjuvant chemotherapy for primary breast cancer显示文摘 | Burcombe RJ Makris A Davies C | 2002 | Breast Cancer Res Treat2002，76，1： | 1 |
| 6 | Evaluation of ER,PgR,HER-2 and ki-67 as Predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ A Makris A | 2005 | Br J Cancer2005，92，1： | 1 |
| 7 | Evaluation of ER,PgR,HER2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 8 | Evaluation of ER,PR,HER-2,and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | BURCOMBE RJ MAKRIS A RICHMAN PI | 2005 | Br J cancer2005，92，1： | 1 |
| 9 | Evaluation of ER,PgR, HER - 2 and Ki - 67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer 显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 10 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，： | 1 |
| 11 | Evaluation of ER,PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer 显示文摘 | Burcombe RJ Makrie A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 12 | Vascular endothelial growth factor fails to predict response to neoadjuvant chemotherapy for primary breast cacer 显示文摘 | Burcombe RJ Makris A Davies C | 2002 | Breast Cancer Res Treat2002，76，1： | 1 |
| 13 | Vascular endothelial growth factor fails to predict response to neoadjuvant chemotherapy for primary breast cancer显示文摘 | Burcombe RJ Makris A Davies C | 2002 | Breast Cancer Res Treat2002，76，1： | 1 |
| 14 | The role of staging CT scans in the treatment of prostate cancer:a retrospective audit显示文摘 | Burcombe RJ Ostler PJ Ayoub AW | 2000 | Clin Oncol2000，12，1： | 1 |
| 15 | Evaluation of ER, PgR, HER -2 and Ki -67 as predictors of response to neoadju- vant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | British J Cancer2005，92，1： | 1 |
| 16 | Vascular endothelial growth factor fails to predict response to neeadjuvant chemotherapy for primary breast cancer显示文摘 | Makris A Davies C | 2002 | Breast Cancer Res Treat2002，76，1： | 1 |
| 17 | A systematic review of the role of pulmonary irradiation in the management of primary bone tumors显示文摘 | Whelan JS Burcombe RJ Janinis J | 2002 | Ann Oncol2002，13，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员